Your browser doesn't support javascript.
loading
Porphyromonas gingivalis promotes progression of esophageal squamous cell cancer via TGFß-dependent Smad/YAP/TAZ signaling.
Qi, Yi-Jun; Jiao, Ye-Lin; Chen, Pan; Kong, Jin-Yu; Gu, Bian-Li; Liu, Ke; Feng, Dan-Dan; Zhu, Ya-Fei; Ruan, Hao-Jie; Lan, Zi-Jun; Liu, Qi-Wei; Mi, You-Jia; Guo, Xiang-Qian; Wang, Ming; Liang, Gao-Feng; Lamont, Richard J; Wang, Huizhi; Zhou, Fu-You; Feng, Xiao-Shan; Gao, She-Gan.
Afiliação
  • Qi YJ; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, P. R. China.
  • Jiao YL; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, P. R. China.
  • Chen P; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, P. R. China.
  • Kong JY; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, P. R. China.
  • Gu BL; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, P. R. China.
  • Liu K; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, P. R. China.
  • Feng DD; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, P. R. China.
  • Zhu YF; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, P. R. China.
  • Ruan HJ; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, P. R. China.
  • Lan ZJ; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, P. R. China.
  • Liu QW; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, P. R. China.
  • Mi YJ; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, P. R. China.
  • Guo XQ; Joint National Laboratory for Antibody Drug Engineering, Medical College of Henan University, Kaifeng, P. R. China.
  • Wang M; Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, P. R. China.
  • Liang GF; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, P. R. China.
  • Lamont RJ; Department of Oral Immunology and Infectious Diseases, University of Louisville School of Dentistry, Louisville, Kentucky, United States of America.
  • Wang H; Department of Oral Immunology and Infectious Diseases, University of Louisville School of Dentistry, Louisville, Kentucky, United States of America.
  • Zhou FY; Department of Thoracic Surgery, Anyang Tumor Hospital, Anyang, China.
  • Feng XS; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, P. R. China.
  • Gao SG; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, P. R. China.
PLoS Biol ; 18(9): e3000825, 2020 09.
Article em En | MEDLINE | ID: mdl-32886690
ABSTRACT
Microbial dysbiosis in the upper digestive tract is linked to an increased risk of esophageal squamous cell carcinoma (ESCC). Overabundance of Porphyromonas gingivalis is associated with shorter survival of ESCC patients. We investigated the molecular mechanisms driving aggressive progression of ESCC by P. gingivalis. Intracellular invasion of P. gingivalis potentiated proliferation, migration, invasion, and metastasis abilities of ESCC cells via transforming growth factor-ß (TGFß)-dependent Drosophila mothers against decapentaplegic homologs (Smads)/Yes-associated protein (YAP)/Transcriptional coactivator with PDZ-binding motif (TAZ) activation. Smads/YAP/TAZ/TEA domain transcription factor1 (TEAD1) complex formation was essential to initiate downstream target gene expression, inducing an epithelial-mesenchymal transition (EMT) and stemness features. Furthermore, P. gingivalis augmented secretion and bioactivity of TGFß through glycoprotein A repetitions predominant (GARP) up-regulation. Accordingly, disruption of either the GARP/TGFß axis or its activated Smads/YAP/TAZ complex abrogated the tumor-promoting role of P. gingivalis. P. gingivalis signature genes based on its activated effector molecules can efficiently distinguish ESCC patients into low- and high-risk groups. Targeting P. gingivalis or its activated effectors may provide novel insights into clinical management of ESCC.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Fator de Crescimento Transformador beta / Infecções por Bacteroidaceae / Porphyromonas gingivalis / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: PLoS Biol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Fator de Crescimento Transformador beta / Infecções por Bacteroidaceae / Porphyromonas gingivalis / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: PLoS Biol Ano de publicação: 2020 Tipo de documento: Article